Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Grass sickness 'shares signs with Alzheimer's'
grazing horses
In the UK, around 2 per cent of horses die from EGS every year.
New study finds link between equine and human conditions

A rare nerve condition of horses may share signs with human brain disorders, a new study has found.

This research offers fresh insight into equine grass sickness (EGS), a rare but largely fatal condition of horses. Edinburgh scientists say their research may help to develop new diagnostic tools.

In the UK, around 2 per cent of horses die from EGS every year. It attacks the nerve cells, causing gastric upset and muscle tremors. Sometimes horses can be nursed back to health if the condition is diagnosed early enough, but more often than not it kills within days.

Researchers from the Roslin Institute and Royal (Dick) School of Veterinary Studies hoped to find out more about the cause of this condition, which is as yet unknown.

When they examined nerve tissue from six horses that died from EGS, they found proteins that are commonly found in the brains of humans with Alzheimer's disease - including amyloid protein.

In total, 506 different proteins were found to be altered in horses with EGS.

Lead author Dr Tom Wishart, from the Roslin Institute, said: "This is the first study to show similarities between an apparently unrelated neurodegenerative disease of large animals and human neurological conditions.

"Although the causes of these conditions are unlikely to be shared, the findings suggest that similar mechanisms could be involved in the later stages of disease."

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'